Other
Baqiyatallah Research Center for Gastroenterology and Liver Diseases
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
100%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT03061032Phase 3Unknown
Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients
Role: collaborator
NCT00707850Phase 4Completed
Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection
Role: collaborator
NCT00707772Phase 4Completed
Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection
Role: collaborator
All 3 trials loaded